Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Godzillarrhea: McNeil Turns To Giant Lizard In Imodium Ad Campaign

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer & Specialty Pharmaceuticals is using a creature-themed television ad campaign to promote its Imodium AD anti-diarrheal

You may also be interested in...



Mucinex “Mr. Mucus” Ads Depart From Professional Detailing Approach

Television and print ads for Adams Respiratory Therapeutics expectorant Mucinex highlight the drug's ability to break up mucus that has settled in the lungs

Lamisil’s “Digger” Tries To Shovel OTC Topicals Out Of Nail Fungus Market

Novartis has modified its RxLamisil (terbinafine) TV ads featuring "Digger," the animated dermatophyte microorganism, to target patients using over-the counter topical therapies

Imodium PR to go

McNeil's Urban Relief Program to promoteImodium anti-diarrheal offers a "creative bathroom solution for travelers" by temporarily placing 10 artistic port-o-potties at parks throughout Manhattan. Bathrooms were "painted and designed by some of New York's top artists," McNeil says. "Offering relief, comfort and visual enjoyment, the exhibit showcases portable bathrooms that are functional, convenient - and works of art - for a quintessential New York minute"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097684

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel